.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
A randomized, double-blind, placebo-controlled trial evaluated whether adding pregabalin to dexamethasone-based multimodal analgesia could improve postoperative pain control in 800 adults undergoing elective 2–3-level lumbar laminectomy. Patients received either 8 or 4 mg intravenous dexamethasone, with or without 150 mg oral pregabalin. The combination of 8 mg dexamethasone plus pregabalin produced the lowest postoperative pain scores and the lowest 24-hour opioid consumption. A significant interaction was also observed between the higher dexamethasone dose and pregabalin. Sedation and dizziness were more frequent in the pregabalin groups (20–22.5% vs 5% with placebo), although there were no significant differences in surgical-site infection or hyperglycemia. The authors concluded that preemptive pregabalin combined with 8 mg dexamethasone may be a useful multimodal analgesic strategy following spinal surgery, while noting the need for further studies to confirm generalizability.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
A randomized, double-blind, placebo-controlled trial evaluated whether adding pregabalin to dexamethasone-based multimodal analgesia could improve postoperative pain control in 800 adults undergoing elective 2–3-level lumbar laminectomy. Patients received either 8 or 4 mg intravenous dexamethasone, with or without 150 mg oral pregabalin. The combination of 8 mg dexamethasone plus pregabalin produced the lowest postoperative pain scores and the lowest 24-hour opioid consumption. A significant interaction was also observed between the higher dexamethasone dose and pregabalin. Sedation and dizziness were more frequent in the pregabalin groups (20–22.5% vs 5% with placebo), although there were no significant differences in surgical-site infection or hyperglycemia. The authors concluded that preemptive pregabalin combined with 8 mg dexamethasone may be a useful multimodal analgesic strategy following spinal surgery, while noting the need for further studies to confirm generalizability.
Today
A randomized trial shows oral DL-3-n-butylphthalide (200 mg thrice daily) significantly slows functional decline in spinocerebellar ataxia type 3 over 12 months, improving SARA and SCAFI scores with favorable safety and zero serious adverse events.
3 days back
Recent research reveals that downregulating YAP1/TAZ-TEAD via Hippo signaling triggers spontaneous human trophoblast syncytialization in 3D cultures, illuminating placental biology and preeclampsia.
Last week
A landmark comparative study evaluates atrial electrophysiology across humans, swine, and rodents. By linking cellular recordings with transcriptomics and in silico modeling, researchers resolve cross-species gaps, explaining translational failures to advance targeted therapies for atrial arrhythmias.
Last week
A novel pathology-adaptive surface engineering strategy uses functionalized plasma polymer coatings to selectively modulate AGE adsorption, reducing oxidative stress and restoring bone formation in diabetic and aging microenvironments.
last month
Researchers have developed an innovative ultrasound-responsive nano-contrast agent that co-delivers CIITA-siRNA and rapamycin directly to inflamed thyroid tissue, significantly reducing autoimmune injury and thyroid autoantibodies in preclinical models of Hashimoto thyroiditis.
Last week
